Bicara Therapeutics Inc. - COMMON STOCK (BCAX)

CUSIP: 055477103

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
-212,507
SEC-reported price per share
$18.61
Number of holders
13
Value change
-$4,053,611
Number of buys
6
Number of sells
4
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
66,780,286

Security key

055477103

Report period

Q3 2026

Institutions

13

Top holders

10

Ownership snapshot

Top reported holders of BCAX - Bicara Therapeutics Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
9/15
Latest evidence
30 Jun 2026
13F 13D/G 3/4/5 Lead comparable stake: 12% 6 rows are not safely comparable across share classes. 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 12%.

9 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 12%
Invus Global Management, LLC 9.6%
Vestal Point Capital, LP 8.3%
Deep Track Capital, LP 6.2%
BlackRock, Inc. 5.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F 13D/G 3/4/5
Company · Director, 10%+ Owner
12%
Reported 13D/G · 26 Feb 2026
$215,430,432
7,255,993 shares
— 30 Jun 2026
Invus Global Management, LLC
13D/G
Raymond Debbane
9.6%
Reported 13D/G · 30 Jun 2025
$50,656,769
5,216,969 shares
$0 30 Jun 2025
Vestal Point Capital, LP
13F 13D/G
Company
8.3%
Reported 13D/G · 31 Mar 2026
$155,872,500
5,250,000 shares
— 30 Jun 2026
Deep Track Capital, LP
13F 13D/G
Company
6.2%
Reported 13D/G · 31 Mar 2026
$121,729,000
4,100,000 shares
— 30 Jun 2026
BlackRock, Inc.
13F 13D/G
Company
5.4%
Reported 13D/G · 30 Jun 2026
$114,249,784
3,848,090 shares
— 30 Jun 2026
Janus Henderson Group Ltd.
13D/G
4.8%
Reported 13D/G · 30 Jun 2026
$94,147,435
3,171,015 shares
-$4,993,947 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
13
Shares
2,963,446
Rows available
13
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
170
Q3 2026 holders
13
Holder diff
-157
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .